The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

Needham: Maintaining a "buy" rating on Vaxcyte Vaxcyte(PCVX.US) , with a price target raised from $90 to $110.

Citizens: Maintaining its "Outperform" rating on LGI Homes ( LGI Homes, Inc.(LGIH.US) ), while raising its price target from $85 to $95.

Morgan Stanley: Maintaining Alumis' ( Alumis Inc.(ALMS.US) ) rating at "overweight", while raising the price target from $22 to $33.

UBS: Allogene Therapeutics ( Allogene Therapeutics, Inc.(ALLO.US) ) has a preliminary rating of "buy", with a target price of $8.

Stifel: Maintaining a "buy" rating on Outset Medical ( Outset Medical, Inc.(OM.US) ), while lowering the price target from $14 to $8.

The symbol	Classification	Target price	Current price	Percentage of potential increase/decrease	(Classification) Agency
Vaxcyte(PCVX.US)	to lift	$110.0	$46.06	138.82%	Needham
LGI Homes, Inc.(LGIH.US)	to lift	$95.0	$43.15	120.16%	Citizens
Alumis Inc.(ALMS.US)	to lift	$33.0	$17.92	84.15%	Morgan Stanley
Western Copper and Gold Corporation(WRN.US)	to lift	$5.75	$3.17	81.39%	HC Wainwright & Co.
Alumis Inc.(ALMS.US)	to lift	$32.0	$17.92	78.57%	Guggenheim
Allogene Therapeutics, Inc.(ALLO.US)	Initial classification	$8.0	$1.49	436.91%	UBS
Outset Medical, Inc.(OM.US)	cut	$8.0	$4.34	84.33%	Stifel
National CineMedia, Inc.(NCMI.US)	cut	$6.0	$3.77	59.15%	Benchmark
Generac Holdings Inc.(GNRC.US)	cut	$224.0	$141.86	57.9%	B of A Securities
Afya Limited(AFYA.US)	cut	$22.0	$14.8	48.65%	JP Morgan

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

JP Morgan: Maintaining its rating on Arch Capital ( Arch Capital Group Ltd.(ACGL.US) ) at "neutral", while raising its price target from $111 to $117.

Barclays: Maintaining an "underweight" rating on The Cheesecake Factory ( Cheesecake Factory Incorporated(CAKE.US) ), while raising its price target from $48 to $51.

Barclays: Maintaining a "Market-Similar Weight" rating for Cava Group CAVA Group, Inc.(CAVA.US) , while raising its price target from $52 to $70.

Canaccord Genuity: Maintaining a "buy" rating on Alphabet ( Alphabet Inc. Class A(GOOGL.US) ) stock, while raising the price target from $330 to $390.

Barclays: Maintaining McDonald's McDonald's Corporation(MCD.US) ) rating at "overweight," while raising the target price from $358 to $372

Truist Securities: Maintaining MongoDB, Inc. Class A rating MongoDB, Inc. Class A(MDB.US) ) at "Buy", while raising the price target from $450 to $500.

Piper Sandler: Maintaining an "overweight" rating on ON Semiconductor ( ON Semiconductor Corporation(ON.US) ), while raising the price target from $60 to $65.

B of A Securities: Maintaining a “buy” rating on SanDisk ( Sandisk Corporation(SNDK.US) ), while raising the price target from $300 to $390.

GLJ Research: Maintaining a "Sell" rating on Tesla Tesla Motors, Inc.(TSLA.US) ) stock, while raising the price target from $19.05 to $25.28.

Rosenblatt: Maintaining a "buy" rating on Twilio Twilio, Inc. Class A(TWLO.US) ), raising the price target from $140 to $180.

First Coverage

Freedom Capital Markets: Initial rating for Applied Digital ( Applied Digital(APLD.US) ) at "Buy", with a target price of $36.

UBS: Initial rating for Beam Therapeutics ( Beam Therapeutics(BEAM.US) ) at "neutral", with a price target of $28.

Piper Sandler: Initial rating for Protara Therapeutics ( Protara Therapeutics, Inc.(TARA.US) ) at "overweight", with a target price of $24.

Citizens: Initial rating for Taylor Morrison Home ( Taylor Morrison Home Corporation(TMHC.US) ) at "outperforms the market", with a price target of $95.

Citizens: Initial rating for Toll Brothers Toll Brothers, Inc.(TOL.US) ) stock at "outperform," with a price target of $175.

UBS: Ventyx Biosciences ( Ventyx Biosciences, Inc.(VTYX.US) ) has a preliminary rating of "buy" on its stock, with a target price of $20.

UBS: Initial rating for Zai Lab ( Zai Lab Limited Unsponsored ADR(ZLAB.US) ) stock at "Buy", with a target price of $35.

reduction

Cantor Fitzgerald: Downgraded BigBear.ai Holdings, Inc. ( BigBear.ai Holdings, Inc.(BBAI.US) ) stock to "neutral", with a price target cut from $7 to $6.

Truist Securities: Maintaining a "Hold" rating on Datadog ( Datadog(DDOG.US) ) stock, while lowering the price target from $195 to $140.

Piper Sandler: Downgraded Deckers Outdoor ( Deckers Outdoor Corporation(DECK.US) ) stock to "underweight," with a price target cut from $100 to $85.

Baird: Downgraded Deckers Outdoor ( Deckers Outdoor Corporation(DECK.US) ) stock rating to "neutral" while maintaining its $125 price target.

Cantor Fitzgerald: Downgraded GitLab GITLAB INC.(GTLB.US) ) stock rating to "neutral", with a price target cut from $60 to $40.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.